Hormel sells maker of Muscle Milk brand to PepsiCo for undisclosed sum

20 Feb 2019 --- Global food company Hormel Foods (Hormel) has sold its CytoSport business to US food and beverage giant PepsiCo for an undisclosed sum, as PepsiCo looks to expand its portfolio of healthier food and beverages. The transaction, which includes the sports and wellness brand Muscle Milk, is subject to customary closing conditions, including regulatory approvals, and is expected to be finalized in 30-60 days.

Fixing a broken food system at Davos 2019: Ellen MacArthur Foundation unveils circular approach

24 Jan 2019 --- By 2050, five million people a year could die due to factors related to the industrial production of food – twice the current number of people killed by obesity. This is according to a report, published by the Ellen MacArthur Foundation, presented at the World Economic Forum (WEF) in Davos. The current food system has supported a fast-growing population and urbanization, but it’s not sustainable nor is it healthy. The harmful impact of pesticides, air and water pollution necessitate a circular economy approach to the food system, the report notes.

Vegan diet more beneficial to heart health than AHA recommended diet

10 Dec 2018 --- A comparative study by the American Heart Association (AHA) has shown that a vegan diet is more effective in reducing the risk of coronary heart disease than the AHA recommended diet.

Enhanced beverage portfolio: Keurig Dr Pepper to acquire Core in US$525m deal

28 Sep 2018 --- Keurig Dr Pepper (KDP) has entered into a definitive agreement to acquire enhanced beverage company Core Nutrition LLC at a value of US$525 million, or approximately US$435 million net of anticipated tax benefits. The acquisition represents KDP's latest move in the evolution of its allied brands portfolio.

Evolva net loss narrows, on track to deliver on set targets

10 Aug 2018 --- Swiss-headquartered biotechnology and fermentation ingredient supplier Evolva has reported that product sales doubled, reaching CHF1.8 million (US$1.8 million) in the first half of 2018. Total revenues reached CHF3.8 million in the first half of 2018, up 6% on last year, while their net loss narrowed to CHF14.7 million (first half 2017 loss CHF20.3 million).

DSM pursues biotin patent suit against China’s Anhui Tiger

07 Aug 2018 --- DSM is pursuing a patent infringement lawsuit in China against a competitor for what it calls the “misappropriation of intellectual property” pertaining to the production of a key ingredient of Biotin (also known as Vitamin B7 or Vitamin H). On August 2, 2018, DSM IP Assets BV and two related operating group companies, DSM Vitamins (Shanghai) Ltd. and DSM Vitamins Trading (Shanghai) Ltd. served a suit against Anhui Tiger in China for patent infringement.

Slendacor: Endorsement for study design on weight management solution

07 Aug 2018 --- PLT Health Solutions, Inc. has revealed the results of a clinical study the company helped develop has been published in the highly-regarded scientific journal, Diabetes, Obesity and Metabolism. Entitled “Efficacy of a novel herbal formulation for weight loss demonstrated in a 16‐week randomized, double‐blind, placebo‐controlled clinical trial with healthy overweight adults” (Dixit, et al. 2018), the publication describes clinical evaluation of Slendacor Weight Management Complex, which was introduced to the market in 2017.

Botanical expansion: Sensient Technologies acquires Mazza Innovation

13 Jul 2018 --- Sensient Technologies Corporation, a global supplier of colors, flavors and fragrances, has acquired Canadian botanical extraction company Mazza Innovation. Effective immediately, the acquisition comes just one week after Mazza Innovation announced an exclusive, long-term supply agreement with BASF, under which the Canadian company will use its PhytoClean Method to provide BASF with specific plant extracts to develop new solutions for cosmetic applications. Mazza Innovation CEO Benjamin Lightburn tells NutritionInsight that the terms of the acquisition have not been disclosed, adding that the company will continue to support all of its existing customers, including BASF and this partnership.

DMK’s “sweeping transformation” in full swing as turnover rises to €5.8bn

22 Jun 2018 --- German dairy cooperative and company, the DMK Group has gone through some significant changes that have given rise to a €5.8 billion turnover, paying above-average milk prices to dairy farmers and becoming Europe’s largest supplier of milk produced without genetic modification.

Lonza: Positive start to 2018, driven by expanding healthcare businesses

04 May 2018 --- Lonza has reported a “positive” start to 2018 led by the businesses along the healthcare continuum. The former Capsugel business, now part of Lonza Pharma & Biotech and Lonza Consumer Health, has shown a strong performance following good progress on business and functional integration, the company reports, without giving any details on financial figures. For the coming months, Lonza has announced plans to expand facilities in the US.

Dynamic OTC marketplace: Albertsons and Rite Aid merge, Amazon enters the fray

21 Feb 2018 --- Albertsons Companies, one of the US’ largest grocery retailers, and leading drugstore chain Rite Aid Corporation have announced a definitive merger agreement, creating a retail behemoth with US$83 billion in annual revenue. The move is thought to give the integrated company more weight to compete with bigger chains in an industry anxious about the reported entry of Amazon.com.

Consumer health care: Nestle loses interest in Merck's OTC unit 

05 Feb 2018 --- Nestle has pulled out of the bid for Merck’s consumer health unit, leaving the race to buy the maker of Seven Seas vitamins and various other nutritional supplements without its main contender, Reuters reports. The news came a week after Johnson & Johnson withdrew from the race to buy US drugmaker Pfizer’s consumer health business, leaving Nestlé, GlaxoSmithKline and Reckitt Benckiser among the potential bidders.

Nestlé and GSK among potential bidders for Pfizer's consumer health unit, after J&J pulls out of race

29 Jan 2018 --- Johnson & Johnson has withdrawn from the race to buy US drugmaker Pfizer’s consumer health business, leaving Nestlé, GlaxoSmithKline and Reckitt Benckiser among the potential bidders, according to Reuters. Pfizer wants to sell the business, which makes Advil painkillers, Centrum multivitamins and Chapstick lip balm, for no less than US$20 billion, sources have told Reuters. The deadline to submit non-binding offers for the unit is on Thursday.

EFSA rejects Unilever black tea health claim

18 Jan 2018 --- The European Food and Safety Authority (EFSA) has rejected a health claim regarding black tea’s effects on the maintenance of normal endothelium-dependent vasodilation in adults. The application, submitted for authorization of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006 by Unilever, pertained to “black tea beverages, either freshly prepared or reconstituted from water extract powders of black tea, characterized by the content of flavanols (expressed as catechins plus theaflavins) of at least 30 mg per 200 ml serving.”

Fire-stricken BASF plant “back on stream” in March at the earliest

10 Jan 2018 --- BASF confirms that it still expects to start up the Citral plant in Ludwigshafen by March at the earliest following a blaze at the German site last fall. The latest progress reports including the potential availability of products are being detailed by the company which aims to keep customers and industry stakeholders informed of the progress of the repair work.

Kappa Bioscience moves to expand vitamin K2 presence in US with new appointments

13 Dec 2017 --- Kappa Bioscience AS, maker of K2Vital vitamin K2 MK-7, has appointed Garnet Pigden and New Jersey-based D2C to head-up the continued development of Kappa’s position in the US market. The appointment spans the establishment of strategy, infrastructure, partnerships and key accounts in support of an overall objective of solidifying vitamin K2 in mainstream US markets and channels, according to Kappa.

New Biopolis probiotic mix helps reduce topical steroid use by atopic dermatitis patients

07 Dec 2017 --- Biopolis, majority owned by agricultural processor and food ingredient provider Archer Daniels Midland Company (ADM), has introduced a new probiotic mix designed to reduce the need for topical steroid use by Atopic Dermatitis (AD) patients. The clinical research recently published in JAMA Dermatology, an international peer-reviewed general medical journal, shows the benefits of consuming a mix of probiotics in reducing the need for topical steroids by AD patients.

High PUFA levels in children linked to reduced allergy risk

07 Dec 2017 --- High levels of omega 3 and omega 6 polyunsaturated fatty acids in children’s blood are associated with a reduced risk of asthma or rhinitis at the age of 16 years, according to new research from Karolinska Institutet in Sweden. The study is published in The Journal of Allergy and Clinical Immunology.

One in four consumers spend less than five minutes on weekday breakfast: DSM survey

07 Dec 2017 --- DSM has found that one in four consumers spend less than five minutes on breakfast on weekdays, and half of consumers spend less than 15 minutes on breakfast. The findings are some of the results of DSM’s Breakfast Insights survey, which also include suggestions that the main reason for skipping breakfast is lack of time and consumers are paying more attention to the lack of sugar in their breakfast.

Weight management program can put Type 2 diabetes into remission finds Lancet study

06 Dec 2017 --- Type 2 diabetes can be reversed following an intensive weight management program, according to a randomized trial in adults who have had the condition for up to six years, published in The Lancet. The findings lend support to the widespread use of this type of intervention in the routine care of Type 2 diabetes across health services.

loading